Puneet Souda
Stock Analyst at Leerink Partners
(2.35)
# 1,402
Out of 4,667 analysts
214
Total ratings
44.32%
Success rate
-2.58%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MASS 908 Devices | Downgrades: Market Perform | $12 → $4 | $2.56 | +56.25% | 6 | Nov 13, 2024 | |
| VCYT Veracyte | Maintains: Outperform | $35 → $40 | $39.20 | +2.04% | 14 | Oct 17, 2024 | |
| NTRA Natera | Maintains: Outperform | $140 → $150 | $167.88 | -10.65% | 7 | Oct 17, 2024 | |
| HOLX Hologic | Maintains: Outperform | $95 → $90 | $78.04 | +15.33% | 6 | Oct 8, 2024 | |
| WAT Waters | Upgrades: Outperform | $325 → $375 | $357.77 | +4.82% | 15 | Aug 1, 2024 | |
| MYGN Myriad Genetics | Upgrades: Outperform | $25 → $35 | $15.30 | +128.76% | 6 | May 8, 2024 | |
| CYRX Cryoport | Downgrades: Market Perform | $30 → $10 | $6.57 | +52.21% | 6 | Jul 13, 2023 | |
| TMO Thermo Fisher | Maintains: Outperform | $630 | $512.84 | +22.85% | 19 | Jul 6, 2023 | |
| CSTL Castle Biosciences | Maintains: Outperform | $50 → $35 | $28.45 | +23.02% | 11 | Jun 5, 2023 | |
| A Agilent Technologies | Maintains: Outperform | $170 → $145 | $128.57 | +12.78% | 19 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $300 | $233.10 | +28.70% | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $249 → $250 | $131.68 | +89.85% | 19 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $110 | $68.72 | +60.07% | 6 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $75 | $52.70 | +42.31% | 16 | Jan 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $200 | $138.90 | +43.99% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $18 | $2.67 | +574.16% | 6 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $6 | $3.90 | +53.85% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $45 → $30 | $41.11 | -27.03% | 6 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $12 → $15 | $11.02 | +36.12% | 11 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $15 | $15.36 | -2.34% | 9 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $87 | $53.37 | +63.01% | 13 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $140 | $30.68 | +356.32% | 5 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20,000 → $15,000 | $0.46 | +3,248,059.38% | 5 | Jan 27, 2021 |
908 Devices
Nov 13, 2024
Downgrades: Market Perform
Price Target: $12 → $4
Current: $2.56
Upside: +56.25%
Veracyte
Oct 17, 2024
Maintains: Outperform
Price Target: $35 → $40
Current: $39.20
Upside: +2.04%
Natera
Oct 17, 2024
Maintains: Outperform
Price Target: $140 → $150
Current: $167.88
Upside: -10.65%
Hologic
Oct 8, 2024
Maintains: Outperform
Price Target: $95 → $90
Current: $78.04
Upside: +15.33%
Waters
Aug 1, 2024
Upgrades: Outperform
Price Target: $325 → $375
Current: $357.77
Upside: +4.82%
Myriad Genetics
May 8, 2024
Upgrades: Outperform
Price Target: $25 → $35
Current: $15.30
Upside: +128.76%
Cryoport
Jul 13, 2023
Downgrades: Market Perform
Price Target: $30 → $10
Current: $6.57
Upside: +52.21%
Thermo Fisher
Jul 6, 2023
Maintains: Outperform
Price Target: $630
Current: $512.84
Upside: +22.85%
Castle Biosciences
Jun 5, 2023
Maintains: Outperform
Price Target: $50 → $35
Current: $28.45
Upside: +23.02%
Agilent Technologies
May 24, 2023
Maintains: Outperform
Price Target: $170 → $145
Current: $128.57
Upside: +12.78%
May 1, 2023
Initiates: Outperform
Price Target: $300
Current: $233.10
Upside: +28.70%
Feb 8, 2023
Maintains: Outperform
Price Target: $249 → $250
Current: $131.68
Upside: +89.85%
Feb 3, 2023
Maintains: Outperform
Price Target: $125 → $110
Current: $68.72
Upside: +60.07%
Jan 12, 2023
Maintains: Outperform
Price Target: $70 → $75
Current: $52.70
Upside: +42.31%
Jan 6, 2023
Maintains: Outperform
Price Target: $230 → $200
Current: $138.90
Upside: +43.99%
Jan 6, 2023
Maintains: Outperform
Price Target: $20 → $18
Current: $2.67
Upside: +574.16%
Nov 29, 2022
Initiates: Outperform
Price Target: $6
Current: $3.90
Upside: +53.85%
Nov 21, 2022
Maintains: Market Perform
Price Target: $45 → $30
Current: $41.11
Upside: -27.03%
Nov 9, 2022
Maintains: Market Perform
Price Target: $12 → $15
Current: $11.02
Upside: +36.12%
Nov 9, 2022
Maintains: Outperform
Price Target: $12 → $15
Current: $15.36
Upside: -2.34%
May 5, 2022
Maintains: Outperform
Price Target: $85 → $87
Current: $53.37
Upside: +63.01%
Feb 24, 2022
Maintains: Outperform
Price Target: $170 → $140
Current: $30.68
Upside: +356.32%
Jan 27, 2021
Maintains: Outperform
Price Target: $20,000 → $15,000
Current: $0.46
Upside: +3,248,059.38%